Myers Scott Dunseth (CIK 1356256) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy ZNTL (57,100 shares), Sell DVAX (3,800 shares), Sell DVAX (31,204 shares), Buy DVAX (3,800 shares), Buy ZNTL (57,603 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Director | Buy | 57,100 | $0 |
| 2026-02-10 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Director | Sell | 3,800 | $0 |
| 2026-02-10 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Director | Sell | 31,204 | $0 |
| 2025-08-25 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Director | Buy | 3,800 | $41,116 |
| 2025-06-18 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Director | Buy | 57,603 | $0 |
| 2025-06-13 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Director | Buy | 5,758 | $0 |
| 2025-04-30 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Director | Buy | 21,000 | $29,400 |
Source: SEC Form 4 filings · as of 2026-06-18